India's leading direct-to-consumer clear aligner tech brand, toothsi has raised $40 million in Series C funding. Our Ventures teams in India and Japan participated in the round alongisde South Korea based Paramark, IIFL and the family office of Medlife’s Co-founders – Prashant Singh and Tushar Kumar.
Existing investors Think Investments and the Mankekar family office also participated along with select independent angel investors including the former Managing Director of HDFC Bank Aditya Puri, Managing Partner of Bain & Company's India offices Karan Singh.
Founded in 2018 by eminent orthodontists, Arpi Mehta Shah, Pravin Shetty, Manjul Jain & Anirudh Kale, toothsi has already designed smile makeovers for 140,000 customers in India, providing them with access to at-home, new-age teeth straightening with invisible, 3D-printed clear aligner technology. toothsi holds itself to the highest global standards, given the stringent focus on quality orientation set by its orthodontist co-founders, some of whom are pioneers in Invisible orthodontics. It is the only Indian consumer facing aligner brand with ISO and CE certified in-house aligner manufacturing and treatment planning capabilities.
Dr. Arpi, Co-founder & CEO, toothsi, said, “We intend to be the one stop platform for doctor directed solutions across cosmetic dental and dermatology. The support of our investors has enabled us to execute on our vision of building a first of its kind, Clinical Beauty Technology brand. We intend to use this capital to build a great team for further geographic penetration and category expansion.”
The company has been growing its consumer and revenue base strongly. It aims to further scale its technology platform and operations to provide a seamless customer experience throughout the treatment journey and also invest in robotic automation for aligner manufacturing. With a distribution network of 2,000+ partner dental centres, toothsi's services are available pan-India. They intend to further deepen their penetration in tier II cities to ensure customers with limited access to orthodontic care can avail the offering.
Read more about their Series C funding round here
